Gyvastė - Company finances
|
EUR
|
2023
From: 2023-05-18
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|
|
Financial data
|
|||
| Sales revenue | 7,240 | 2,790 | 2,950 |
| Profit before tax | 4,568 | 954 | 199 |
| Net profit | 4,568 | 936 | 187 |
| Equity | 4,668 | 5,609 | 5,796 |
| Liabilities | 12 | 31 | 50 |
| Non-current assets | 0 | 0 | 0 |
| Current assets | 4,680 | 5,640 | 5,846 |
| Total assets | 4,680 | 5,640 | 5,846 |
|
Taxes paid
|
|||
| STI taxes | - | - | 18 |
|
Financial indicators
|
|||
| Revenue change y/y | - | -61.5% | +5.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 97.6% | 16.6% | 3.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 97.9% | 16.7% | 3.2% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 63.1% | 33.5% | 6.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 63.1% | 34.2% | 6.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.0 | 0.0 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Gyvastė - Social security debts
The company had no debts to Sodra
Gyvastė - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-03-20 | 2025-06-26 | 1.36 |
| 2025-03-12 | 2025-03-19 | 18.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Gyvaste, MB (code 306321261) is a Small partnership engaged in the manufacture of other medical and dental devices, instruments and supplies. In 2025, the company generated revenue of €3.0K and net profit of €187, compared with €2.8K revenue and €936 net profit in 2024. The revenue trend over the last three years shows a sharp decline from €7.2K in 2023 to €2.8K in 2024, followed by a modest recovery in 2025. Profitability weakened over the same period, with net margin falling from 63.1% in 2023 to 33.5% in 2024 and 6.3% in 2025. Balance sheet totals remained stable and low, with total assets and equity both at €5.8K in 2025, while liabilities increased slightly to €50. The company’s equity ratio stood at 99.1%, indicating very low leverage, and debt-to-equity was 0.01. Return on equity and return on assets were both 3.2% in 2025, while asset turnover was 0.50x, reflecting limited asset utilization relative to revenue.